Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
US Department of Justice
Express Scripts
Teva
Cantor Fitzgerald
Accenture
Argus Health
Fish and Richardson

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MIDODRINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Midodrine Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00004268 Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension Completed Roberts Pharmaceutical Phase 2 OBJECTIVES: I. Study further the safety and efficacy of the alpha-receptor agonist midodrine in patients with neurogenic orthostatic hypotension. II. Assess the quality of life in these patients with this treatment regimen.
NCT00004268 Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension Completed National Center for Research Resources (NCRR) Phase 2 OBJECTIVES: I. Study further the safety and efficacy of the alpha-receptor agonist midodrine in patients with neurogenic orthostatic hypotension. II. Assess the quality of life in these patients with this treatment regimen.
NCT00004479 Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope Completed Icahn School of Medicine at Mount Sinai N/A OBJECTIVES: Determine the efficacy of midodrine, a selective alpha 1 adrenergic agonist, in preventing neurally mediated syncope.
NCT00046163 A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension Terminated Shire Phase 4 We are seeking male and female patients to voluntarily take part in a clinical research study. Patients must be aged 18 or older and diagnosed with symptomatic orthostatic hypotension (low blood pressure while in the upright position) due to Parkinson's disease, multiple system atrophy, pure autonomic failure or autonomic neuropathies (i.e. neurogenic orthostatic hypotension). Symptoms of low blood pressure include dizziness, lightheadedness, changes in vision and generalized weakness upon standing. The main effect of the drug being studied is to increase blood pressure in the upright position so symptoms will decrease. The purpose of this clinical study is to further assess the clinical effect of high dose midodrine hydrochloride (ProAmatine®), an approved treatment for orthostatic hypotension. During the course of the study, participants will receive either ProAmatine® or a placebo. Assessments will be made using questionnaires that measure symptom and activity levels. Blood pressure in the lying down, sitting and standing positions will be measured. Patients will also complete standing time assessments. They will be asked to remain standing without moving until they feel sufficiently lightheaded, or dizzy, or feel faint so that they would feel more comfortable sitting down.
NCT00046475 A Study for Patients With Neurogenic Orthostatic Hypotension Completed Shire Phase 4 We are seeking male and female patients to voluntarily take part in a clinical research study. Patients must be aged 18 or older and diagnosed with symptomatic orthostatic hypotension (low blood pressure while in the upright position) due to Parkinson's disease, multiple system atrophy, pure autonomic failure or autonomic neuropathies (i.e. neurogenic orthostatic hypotension). Symptoms of low blood pressure include dizziness, lightheadedness, changes in vision and generalized weakness upon standing. The main effect of the drug being studied is to increase blood pressure in the upright position so symptoms will decrease. The purpose of this clinical study is to further assess the clinical benefit of midodrine hydrochloride (ProAmatine®), an approved treatment for orthostatic hypotension. During the course of the study, participants will receive either ProAmatine® or a placebo. Assessments will be made using questionnaires that measure symptom and activity levels. Blood pressure in the lying down and standing positions will be measured at each visit.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Midodrine Hydrochloride

Condition Name

Condition Name for Midodrine Hydrochloride
Intervention Trials
Orthostatic Hypotension 9
Cirrhosis 6
Spinal Cord Injury 5
Hypotension 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Midodrine Hydrochloride
Intervention Trials
Hypotension 28
Hypotension, Orthostatic 22
Liver Cirrhosis 7
Fibrosis 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Midodrine Hydrochloride

Trials by Country

Trials by Country for Midodrine Hydrochloride
Location Trials
United States 168
Canada 23
Australia 6
New Zealand 4
Spain 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Midodrine Hydrochloride
Location Trials
New York 21
Tennessee 10
Texas 9
Ohio 8
Florida 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Midodrine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Midodrine Hydrochloride
Clinical Trial Phase Trials
Phase 4 15
Phase 3 11
Phase 2/Phase 3 4
[disabled in preview] 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Midodrine Hydrochloride
Clinical Trial Phase Trials
Completed 28
Recruiting 18
Not yet recruiting 8
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Midodrine Hydrochloride

Sponsor Name

Sponsor Name for Midodrine Hydrochloride
Sponsor Trials
James J. Peters Veterans Affairs Medical Center 7
Chelsea Therapeutics 6
Vanderbilt University 5
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Midodrine Hydrochloride
Sponsor Trials
Other 52
Industry 20
U.S. Fed 11
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Dow
Colorcon
Queensland Health
Chinese Patent Office
Federal Trade Commission
Accenture
Express Scripts
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.